<DOC>
	<DOCNO>NCT01950884</DOCNO>
	<brief_summary>- NAFLD ( Non-alcoholic fatty liver disease ) become common cause liver disease Western country ( hepatic manifestation insulin resistance ) ; - NAFLD represent cardiovascular risk factor ; - Lifestyle modification ( weight loss ) effective medical treatment recommend NASH ( Non-alcoholic Steatohepatitis ) ; - Ezetimibe could represent novel safe treatment NAFLD ( Patel 2006 . Here investigator propose Randomized Controlled Pilot Trial evaluate addictive effect ezetimibe liver histology , biochemical sonographic parameter small ( n.40 ) number NASH patient randomize 12 month two arm : lifestyle v lifestyle+ezetimibe .</brief_summary>
	<brief_title>Lifestyle Versus Ezetimibe Plus Lifestyle Patients With Non-alcoholic Steatohepatitis</brief_title>
	<detailed_description>evaluate addictive effect ezetimibe liver histology , biochemical sonographic parameter small ( n.40 ) number NASH patient randomize 12 month two arm : lifestyle v lifestyle+ezetimibe .</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>1.Patients older 18 year 2.Histological diagnosis possible definite NASH , accord Kleiner scorw , within 6 month randomization 1 ) Average alcohol consumption &gt; 20 g per day woman &gt; 30 g per day men 2 ) cause chronic liver disease 3 ) History plan gastrointestinal bypass additional bariatric surgery/intervention 4 ) Hepatic cirrhosis ChildPugh score B C , and/or concomitant HCC 5 ) Recent ( within 6 month ) concomitant use agent know cause hepatic steatosis 7 ) Recent ( within 6 month ) change dose/regimen first treatment vitamin E , C , betaine , sadenosylmethionine , ursodeoxycholate , sylimarin , fibrate , statin , pentoxyfilline , angiotensin II inhibitor , orlistat , sibutramine 8 ) Ongoing recent therapy ( within 6 month ) vitamin D medication know affect vitamin D3 metabolism 9 ) Any additional condition might interfere optimal partecipation study , accord Investigators opinion ; 10 ) Be pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>â€¢Non-alcoholic Steatohepatitis ( NASH )</keyword>
</DOC>